New Paul Hopper Interview, page-25

So much crap being posted here about consolidation.

Consol/ No consul is irrelevant to this company's future (or any other's for that matter). The important factor for an R&D non income generating outfit (as we are) is the results of that R&D -  i.e. demonstrated efficacy (or high probability thereof). That is what, at the pointy end, determines market cap, which apart from short term ignorant psychology, is not dependent on the number of shares on issue - the resultant SP (cps) takes care of that. For goodness sake WAKE UP!

[Consolidation does increase the 'potential' for greater liquidity. Why? Because percentage wise it creates more trading intervals. Post consol the big test is, is the company worth this advantage. In IMU's case who knows. Only results will tell.]